Serenex Inc.

Serenex has built a high-throughput affinity displacement discovery platform that enhances compound-target identification and helps spot likely sources of toxicity very early in the discovery process. The company is applying its technology for a growing list of partners, but also aims to build a drug discovery business of its own.